Better predictions. Better decisions. Entelos proprietary physiological mechanistic modeling technology accelerates the discovery and development of pharmaceutical therapies and consumer products. We maximize success through better design of clinical trials and better product development decisions.
We are best known for our strength in the prediction of outcomes for all steps on the path to drug commercialization, from discovery to completion of Phase III and post-marketing trials. But not only do our platforms model pharmaceutical therapies, they also model consumer products, foods, and cosmetics for human and veterinary applications. Modeling is a means of non-invasive research.
For over 15 years, Entelos has been enhancing its in silico modeling software and platforms created by our teams of scientists, mathematical modelers, and programmers. Our PhysioLab platforms represent years of careful calibration and validation using actual clinical and peer-reviewed public data. Our Virtual Patients and Virtual Populations enhance predictions for all phases of discovery and clinical trials. The result is better understanding of patient variation, better target identification, more efficient trial design and biomarker analysis - providing more options when development seems cumbersome or blocked. The beneficiaries of our modeling efforts include the FDA and many major pharmaceutical and consumer product companies.
Link up your social media account to automatically promote the positions at Entelos.
Get a job alert every time Entelos posts a job.
Entelos does not have any jobs posted at this time.